000504 *ST南华生物
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--05,4165,4845,975
投资性房地产0--0000
固定资产12,777-5.31%13,49414,28220,36216,509
在建工程0--0001,286
无形资产2,34426.23%1,857441361218
商誉1,9830.00%1,9831,9838,4418,441
其他非流动资产89,807-52.47%188,93194,410102,481110,193
106,911-48.17%206,266116,531137,130142,622

流动资产
货币资金140,177-32.40%207,363493,811218,148153,005
应收账款122,942-11.92%139,582123,224158,759196,119
存货18,191-46.59%34,05910,6604,50110,640
其他流动资产206,868889.75%20,90127,15534,828156,860
488,17821.47%401,904654,851416,236516,623

流动负债
短期借款0--028,11763,08332,910
应付票据0--0000
应付帐款86,5652.49%84,46682,21382,03289,562
其他流动负债223,3741.07%221,005342,068310,037406,531
309,9391.46%305,471452,397455,152529,002
流动资产净值178,24084.83%96,433202,454(38,916)(12,379)
资产总额减流动负债285,150-5.80%302,699318,98698,215130,243

非流动负债
长期借款8,500-5.56%9,000000
应付债券0--0000
其他非流动负债8,948-23.53%11,70114,31218,02919,924
17,448-15.71%20,70114,31218,02919,924

总权益
    实收股本330,0230.00%330,023330,023311,574311,574
    储备项目(96,412)3.75%(92,928)(73,082)(297,565)(294,934)
股东权益233,611-1.47%237,095256,94114,00916,640
非控股权益34,091-24.08%44,90347,73366,17793,679